Non-COVID-19 respiratory viral infection

TY - JOUR

T1 - Non-COVID-19 respiratory viral infection

AU - Nunes-Silva, Cláudio

AU - Vilares, Ana Teresa

AU - Schweitzer, Valentijn

AU - Castanhinha, Susana

AU - Martins, António

AU - Lopes, Maria João

AU - Ascoli-Bartoli, Tommaso

AU - Canelas, Gabriela

AU - Keir, Holly R.

AU - Cunha, Flávia

AU - Silva-Pinto, André

AU - Rebelo, Sandra

AU - Cunha, Rui Guimarães

AU - Tavares, Margarida

N1 - Publisher Copyright: © ERS 2022.

PY - 2022/5/9

Y1 - 2022/5/9

N2 - Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed.

AB - Implemented control measures brought about by the coronavirus disease 2019 (COVID-19) pandemic have changed the prevalence of other respiratory viruses, often relegating them to a secondary plan. However, it must not be forgotten that a diverse group of viruses, including other human coronaviruses, rhinoviruses, respiratory syncytial virus, human metapneumoviruses, parainfluenza and influenza, continue to be responsible for a large burden of disease. In fact, they are among the most common causes of acute upper and lower respiratory tract infections globally. Viral respiratory infections can be categorised in several ways, including by clinical syndrome or aetiological agent. We describe their clinical spectrum. Distinctive imaging features, advances in microbiological diagnosis and treatment of severe forms are also discussed.

UR - https://www.scopus.com/pages/publications/85130700680

U2 - 10.1183/20734735.0151-2021

DO - 10.1183/20734735.0151-2021

M3 - Review article

C2 - 36338246

AN - SCOPUS:85130700680

SN - 1810-6838

VL - 18

JO - Breathe

JF - Breathe

IS - 1

M1 - 210151

ER -